Concomitant Radiotherapy with Protracted 5-fluorouracil Infusion in Locally Advanced Carcinoma of the Pancreas: A Phase Ii Study

Bakkevold K.E. , Kambestad B. : Morbidity and mortality after radical and palliative pancreatic cancer surgery. Risk factors influencing the short-term results. Ann Surg, 217: 358–368, 1993.

Boring C.C. , Squires T.S. , Tong T. : Cancer Statistics. CA, 41: 19–36, 1991.

Ettinghausen S.E. , Schwartzentruber D.J. , Sindelar W.F. : Evolving strategies for the treatment of adenocarcinoma of the pancreas. A review. J Clin Gastroenterol, 21: 48–60, 1995.

Gastrointestinal Tumor Study Group. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads+5-fluorouracil), and high dose radiation + 5-fluorouracil. Cancer, 48: 1705–1710, 1981.

Gastrointestinal Tumor Study Group. Therapy of locally unresectable pancreatic carcinoma: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. J Natl Cancer Inst, 80: 751–755, 1988.

Hoffman J.L. , Weese J.L. , Solin L.J. , Engstrom P. , Agarwal P. , Barber L.W. , Guttmann M.C. , Litwin S. , Salazar H. , Eisenberg B.L. : A pilot study of preoperative chemoradiation for patients with localized adenocarcinoma of the pancreas. Am J Surg, 169: 71–78, 1995.

Ishii H. , Okada S. , Tokuuye K. , Nose H. , Okusaka T. , Yoshimori M. , Nagahama H. , Sumi M. , Kagami Y. , Ikeda H. : Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma. Cancer, 79: 1516–1520, 1997.

Kelsen D. : Neoadjuvant therapy for upper gastrointestinal tract cancers. Curr Opinion Oncol, 8: 321–328, 1996.

Moertel C.G. , Childs D.S. , Reitemeier R.J. , Colby M.Y. , Holbrook M.A. : Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet, 2: 865–867, 1969.

Gunderson L.L. , Willett C.G. : Pancreas and hepatobiliary tract. In: Principles and Practice of Radiation Oncology, Perez C.A. , Brady L.W. (eds), 1467–1488, Lippincott-Raven, Philadelphia, 1997.

World Health Organization. WHO handbook for reporting results of cancer treatment. Offset Publication 48. World Health Organization, Geneva, 1979.

Kaplan E.L. , Meier P. : Nonparametric estimation from incomplete observations. J Am Stat Assoc, 63: 457–481, 1958.

Nix G. , Dubbelman C. , Wilson J. , Shuttle H.E. , Jeekel J. , Postema R.R. : Prognostic implication of tumor diameter in carcinoma of the head of the pancreas. Cancer, 67: 529–535, 1991.

Martenson J.A. , Swaminathan R. , Burch P.A. , Santala R.G. , Schroeder G. , Pitot H.C. , Wright K. , Kugler J.W. , Stella P.J. , Garton G.R. : Pilot study of continuous-infusion 5-fluorouracil, oral leucovorin, and upper-abdominal radiation therapy in patients with locally advanced residual or recurrent upper gastrointestinal or extrapelvic colon cancer. Int J Radiat Oncol Biol Phys, 37: 615–618, 1997.

Miller A.R. , Robinson E.K. , Lee J.E. , Pisters P.W. , Chiao P.J. , Lenzi R.L. , Abbruzzese J.L. , Evans D.B. : Neoadjuvant chemoradiation for adenocarcinoma of the pancreas. Surg Oncol Clin N Am, 7: 183–197, 1998.

MacMillan W.E. , Wobery W.H. , Welling I.G. : Pharmacokinetics of 5-fluorouracil in humans. Cancer Res, 38: 3479–3482, 1978.

Lawrence T.S. , Chang E.Y. , Hahn T.M. , Hertel L.W. , Shewac D.S. : Radiosensitization of pancreatic cancer cells by 2′,2′-difluoro-2′-deoxycytidine. Int J Radiat Oncol Biol Phys, 34: 867–872, 1996.

Poen J.C. , Collins H.L. , Niederhuber J.E. , Oberhelman H.A. , Vierra M.A. , Bastidas A.J. , Young H.S. , Slosberg E.A. , Jeffrey B.R. , Longacre T.A. , Fisher G.A. , Goffinet D.R. : Chemo-radiotherapy for localized pancreatic cancer: increased dose intensity and reduced acute toxicity with concomitant radiotherapy and protracted venous infusion 5-fluorouracil. Int J Radiat Oncol Biol Phys, 40: 93–99, 1998.

Garton G.R. , Gunderson L.L. , Nagorney D.M. , Donohue J.H. , Kirk Martin J. , MacIrlath D.C. , Cha S.S. : High-dose preoperative external beam and intraoperative irradiation for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys, 27: 1153–1157, 1993.

Mohiuddin M. , Regine W.F. , Stevens J. , Rosato F. , Barbot D. , Biermann W. , Cantor R. : Combined intraoperative radiation and perioperative chemotherapy for unresectable cancers of the pancreas. J Clin Oncol, 13: 2764–2768, 1995.

Kornek G.V. , Schratter-Sehn A. , Marczell A. , Depisch D. , Karner J. , Krauss G. , Haider K. , Kwasny W. , Locker G. , Scheithauer W. : Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin. Br J Cancer, 82: 98–103, 2000.

Hoffman J.P. , Lipsitz S. , Pisansky T. , Weese J.L. , Solin L. , Al Benson B. III : Phase II Trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: An Eastern Cooperative Oncology Group Study. J Clin Oncol, 16: 317–323, 1998.

Yeung R.S. , Weese J.L. , Hoffman J.P. , Solin L.J. , Paul A.R. , Engstrom P.F. , Litwin S. , Kowalyshyn M.J. , Eisenberg B.L. : Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. Cancer, 72: 2124–2133, 1993.

Coia L. , Hoffman J. , Scher R. : Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum. Int J Radiat Oncol Biol Phys, 30: 161–167, 1994.

Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer, 59: 2006–2010, 1987.

Blackstock A.W. , Bernard S.A. , Richards F. , Savage P. , Tepper J.E. : Phase I study of concurrent radiation and twice-weekly gemcitabine in advanced/metastatic pancreatic cancer. Proc ASCO, 17: 1015, 1998.

Burris H. , Moore M. , Andersen J. , Green M. , Rothenberg M.L. , Modiano M.R. , Cripps M.C. , Portenoy R.K. , Storniolo A.M. , Tarassoff P. , Nelson R. , Dorr F.A. , Stephens C.D. , Von Hoff D. : Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trial. J Clin Oncol, 5: 2403–2413, 1997.

Hoffman J.L. , McGinn C.J. , Szarka C. , Morphis J. , Cooper H.S. , Wilkes J. , Nicol S. : A phase I study of preoperative gemcitabine with radiation therapy followed by postoperative gemcitabine for patients with localized resectable pancreatic adenocarcinoma. Proc ASCO, 17: 1090, 1998.

McGinn C.J. , Smith D.C. , Szarka C.E. , Pinover W.H. , Loerhrer P.J. , Morphis J.G. , Nicol S. , Shewach T.S. , O'Dwyer P.J. : A phase I study of gemcitabine in combination with radiation therapy in patients with localized unresectable pancreatic cancer. Proc ASCO, 17: 1014, 1998.

Moore M. , Anderson I. , Burris H. , Tarassoff P. , Green M. , Casper E. : A randomized trial of gemcitabine (GEM) versus 5-FU as first-line therapy in advanced pancreatic cancer (abstract 473). Proc Am Soc Clin Onc, 14: 199, 1995.

Wolff R.A. , Evans D.B. , Gravel D.M. , Lenzi R. , Pisters P.W. , Lee J.E. , Janjan N.A. , Goswitz M.S. , Abbruzzese J.L. : Phase I trial of gemcitabine combined with radiation therapy for the treatment of locally advanced pancreatic adenocarcinoma. Proc ASCO, 17: 1091, 1998.